Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andres Forero-Torres, MD
University of Alabama Medical Center
Principal Investigator - Brad Pohlman, MD
The Cleveland Clinic
Principal Investigator - Brian Link, MD
University of Iowa
Principal Investigator - Kristen Ganjoo, MD
Stanford University
Principal Investigator - Markus Mapara, MD, PhD
University of Pittsburgh Medical Center
Principal Investigator - Michael E. Williams, MD
University of Virginia Health Systems
Principal Investigator - Mitchell R. Smith, MD, PhD
Fox Chase Cancer Center
Principal Investigator - Nam Dang, MD
Nevada Cancer Institute
Principal Investigator - Stephanie A. Gregory, MD
Rush University Medical Center
Principal Investigator - Sven de Vos, MD, PhD
University of California, Los Angeles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Medical Center
Birmingham, Alabama, United States
- Ucla Medical Hematology and Oncology
Los Angeles, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- Nevada Cancer Institute
Las Vegas, Nevada, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 31 Jan 2009
- Completion
- 31 Jan 2009
- Last update posted
- 7 Jan 2016
- Registered enrollment
- 67
- Registry id
- NCT00354926
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.